Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > I'm going to dump this dog 🐕
View:
Post by bligicka on Mar 23, 2021 5:16pm

I'm going to dump this dog 🐕

If we don't get protective antibodies by the end of the year !!!
Comment by RobCalifornia on Mar 23, 2021 6:17pm
Nobody cares bud. Which is why you've been talking to yurself on this board all day. LOL. You and Camaro may get along, send him a PM.
Comment by CamaroZL1 on Mar 23, 2021 7:19pm
Nob, if your target is 3 to 5 dollars why not 30 to 50 dollars? That is better right?!
Comment by anchorman1 on Mar 23, 2021 10:40pm
  $30 could be a reality. This COVID isn't going anywhere. If Vaxil has some pieces to the puzzle and big pharma jumps in who knows?
Comment by bligicka on Mar 24, 2021 1:47am
So far their Signal peptides are a failure .....the stock is a pump and dump ...lets hope we break .20 again this year
Comment by kevlin139 on Mar 23, 2021 6:27pm
lmao you said that before  
Comment by saintpeter on Mar 23, 2021 7:10pm
WHY THE FUCCC WAIT TILL THEN SELL SELL tommorow morning hit the bids leave hit the road  lol sp
Comment by bligicka on Mar 23, 2021 7:17pm
Not going to sell at a loss ....if Goren were to step down this stock would skyrocket .....I'm sure the board of directors are looking to get rid of him after his high risk bs experiment that completely damaged this company's reputation
Comment by kevlin139 on Mar 24, 2021 6:50am
  hahha. What about last run to .77. Fool.  You dont have it in you. 
Comment by bligicka on Mar 24, 2021 7:52am
Last run was before we found out the signal peptides couldn't offer protective antibodies .....now everyone knows it was all smoke and mirror hype ....Goren gambled with the company's Vaxhit platform and now the market knows its garbage
Comment by kevlin139 on Mar 24, 2021 8:31am
yet you continue to hold while other opp. Go by.  Your problem blig is you are reactive to stock.  You need to be proactive. I dont think you have it in you to succeed   
Comment by bligicka on Mar 24, 2021 8:36am
Your probably right .....l will just sit here and watch the stock go to zero ...... l'm taking my big cash infusion else where cause l have absolutely no faith Goren will ever get a product to market at this point ....clinical by 2022 l call bs !!!
Comment by anchorman1 on Mar 24, 2021 9:58am
 "Big cash infusion". Don't spend that $20 all in one place.  
Comment by bligicka on Mar 24, 2021 10:04am
Not a penny back to this dog as long as Goren is here
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities